Modifying psychotropic drug prescription patterns:A follow‐up survey

Abstract

Abstract(:ross-sectioii.il surveys of prescription pitterns of psychotropic-drugs provide J quic-k, global cstimatioti of tlic 'iI7I7r('Pri'iteness of psycliopli~iriiiacotlier~i~~~~. Recurrent inadequacies in prescribing for psychiatric pcitients iiiclude 1701y~ili'iriii'icy, high do\es of mtipsychotics (APS), .the use of niultiple APS simultaneously, .ind the adniiiiistrntion of thew drugs in niultiplc divided doses. F'iulty prescribing patterns are diff~cult to anieiid.follow in^ 'I \ui-vcy in rehahilitation f'icility for chronic psychiatric p'iticnts, ' 1 sy\tematic education program . i n d other iiic'istirc\ were introduced to improve p r c x i b i n g h,ibits. Two year\ Liter tlie survey w a s repe~ted. Sigiiificant improvcmcnts were dctcc-tcd in tlic following 'irecis: rcductioiis in the doses of APS md ;rntiparkinsoni~iii (At') drugs, reductions in the nuiiihcr of patients placed on these drugs, and reduction5 in the percent'ige of p.itients receiving multiple sintipsychotics siiiiult'iiieously. Despite these reduc-tions in doses of p\ychotropic .igents, p~tients' rehabilitative po!cntial w i s not coniproiiiised.

Exploring the clinical and social determinants of prescribing anticholinergic medication for Chinese patients with schizophrenia

“…These are mere assumptions and the reasons for this resistance needs to be further investigated. (3) Some clinicians are worried about the rebound phenomena including nausea, abdominal pain, restlessness, insomnia, akinetic depression, and even deterioration of the patients' mental state following the cessation of ACM (Gray and Gournay, 2000;Ungvari et al, 1997).…”

Adjunctive Mood Stabilizer and Benzodiazepine Use in Older Asian Patients with Schizophrenia, 2001–2009

“…Concerns about withdrawal eff ects and deterioration of mental state following the cessation of MS and BZD may prevent psychiatrists from discontinuing these drugs. A sizeable minority of Asian patients and their families are unwilling to give up the earlier prescribed drugs due to fear of relapse even if their therapeutic eff ects are not satisfactory [ 10 ] . Another historical reason is the traditional medical concept in Asia that favors the combination of drugs with diff erent pharmacological properties as more eff ective despite the lack of compelling evidence for this practice [ 24 ] .…”

Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study

“…Prior to the current study, all patients in this facility, including the subjects of the present study, underwent a slow and gradual reduction of antipsychotic and antiparkinsonian medication to optimize their pharmacotherapy (Ungvari et al 1997(Ungvari et al , 1999. Although the majority of catatonic subjects were usually reticent to talk and occasionally they were entirely uncommunicative, withdrawn or even negativistic, in relatively better periods of their illness close relatives/guardians or a well-known nurse was able to obtain written informed consent from all but one patient.…”